{"id":"https://openalex.org/W4411289082","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27","title":"Abstract P5-07-27: BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate, in patients with Locally Advanced or Metastatic Breast Cancer and other Solid Tumor: Updated results from a phase 1 study","display_name":"Abstract P5-07-27: BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate, in patients with Locally Advanced or Metastatic Breast Cancer and other Solid Tumor: Updated results from a phase 1 study","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411289082","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-p5-07-27","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101614303","display_name":"Jiong Wu","orcid":"https://orcid.org/0000-0002-8103-0505","observed_orcids":["https://orcid.org/0000-0002-8103-0505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiong Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jian Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100783340","display_name":"Yiqun Du","orcid":"https://orcid.org/0000-0002-2870-6510","observed_orcids":["https://orcid.org/0000-0002-2870-6510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiqun Du","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103483535","display_name":"Yanchun Meng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanchun Meng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101209261","display_name":"Sa Xiao","orcid":"https://orcid.org/0009-0008-3502-5319","observed_orcids":["https://orcid.org/0009-0008-3502-5319","https://orcid.org/0000-0002-7974-3979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sa Xiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101358435","display_name":"Hai Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hai Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5101050030","display_name":"Yi Zhu","orcid":"https://orcid.org/0009-0006-7134-1189","observed_orcids":["https://orcid.org/0009-0006-7134-1189"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"P5","last_page":"07"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cleavable-linkers","display_name":"cleavable linkers","score":0.878000020980835},{"id":"https://openalex.org/keywords/locally-advanced-or-metastatic-breast-cancer","display_name":"locally advanced or metastatic breast cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9390000104904175},{"id":"https://openalex.org/keywords/dose-expansion","display_name":"dose expansion","score":0.42399999499320984},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6869999766349792},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.5799999833106995},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.44999998807907104},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7194778919219971},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.6652374267578125},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.5937240719795227},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5922359824180603},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5772417187690735},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5158721208572388},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4888876974582672},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4720742702484131},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4498599171638489},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4299563765525818},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.4113209843635559},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3511878550052643},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.26741862297058105},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26146483421325684},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25642645359039307},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16179290413856506},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-p5-07-27","doi":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-p5-07-27","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396591944","https://openalex.org/W4379283085","https://openalex.org/W4387825531","https://openalex.org/W4396588112","https://openalex.org/W4402561888","https://openalex.org/W4413031409","https://openalex.org/W4399119065","https://openalex.org/W4387811508","https://openalex.org/W4362534675","https://openalex.org/W4410455798"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"BL-B01D1":[2,41,292,320],"is":[3,274],"a":[4,20,27,90,348,370],"potentially":[5],"first-in-class":[6,349],"novel":[7,21],"antibody":[8,17],"drug":[9],"conjugate":[10],"(ADC)":[11],"consisting":[12],"of":[13,40,78,86,92,108,245,272,280,313,319,377],"an":[14],"EGFRxHER3":[15,350],"bispecific":[16,351],"bounded":[18],"to":[19,199,205,208],"topoisomerase":[22],"I":[23,38],"inhibitor":[24],"payload":[25],"via":[26],"cleavable":[28],"linker.":[29],"We":[30],"now":[31],"present":[32],"updated":[33],"safety/efficacy":[34],"data":[35],"from":[36,369],"phase":[37,371],"study":[39,48,373],"in":[42,69,224,297,310,354],"breast":[43,58,119,306],"cancer":[44,59,120,307],"(BL-B01D1-104).":[45],"Methods:":[46],"This":[47],"included":[49],"Chinese":[50],"patients":[51,300,355],"(pts)":[52],"with":[53,103,231,236,301,323,356],"locally":[54,304],"advanced":[55,305],"or":[56,359],"metastatic":[57,302],"(BC)":[60],"and":[61,80,234,262,277,303,317,363],"other":[62,364],"solid":[63],"tumors.":[64],"BC":[65,94,131,192,233,238],"pts":[66,95,115,128,138,219,256,283],"were":[67,97,150,220,249],"enrolled":[68],"dose-expansion":[70],"(D-EXP)":[71],"at":[72,104],"2.5mg/kg":[73],"D1D8":[74],"Q3W":[75],"regimen":[76],"regardless":[77],"EGFR/HER3":[79],"HER2":[81,124,134,140],"expression":[82],"levels.":[83],"Results:":[84],"As":[85],"May":[87],"31,":[88],"2024,":[89],"total":[91],"158":[93,112,191,216],"(156":[96],"previously":[98,298,324],"treated)":[99],"have":[100],"been":[101],"treated":[102,299],"least":[105],"one":[106],"dose":[107],"BL-B01D1.":[109,209],"Among":[110,190,214],"the":[111,215,225,278,378],"pts,":[113,193,217],"44":[114],"had":[116,129,139,258],"triple":[117],"negative":[118],"(TNBC)":[121],"including":[122,132],"27":[123],"0":[125,135],"pts;":[126,136],"77":[127],"HR+HER2-":[130,237],"28":[133],"37":[137],"positive":[141],"BC.":[142],"The":[143,267,315],"most":[144],"common":[145],"TRAEs":[146],"(>25%,":[147],"all":[148,281],"grade/\u2265G3)":[149],"anemia":[151],"(90.5%/39.9%),":[152],"leukopenia":[153],"(88.0%/42.4%),":[154],"neutropenia":[155,201],"(85.4%/51.3%),":[156],"thrombocytopenia":[157],"(67.7%/25.3%),":[158],"nausea":[159],"(58.2%/3.8%),":[160],"stomatitis":[161],"(48.7%/3.8%),":[162],"aspartate":[163],"aminotransferase":[164,168],"increased":[165,169],"(45.6%/0%),":[166],"alanine":[167],"(42.4%/0%),":[170],"asthenia":[171],"(42.4%/8.9%),":[172],"vomiting":[173],"(40.5%/0.6%),":[174],"hypertriglyceridemia":[175],"(36.7%/0.6%),":[176],"alopecia":[177],"(32.9%/0%),":[178],"hypokalemia":[179],"(31.6%/3.8%),":[180],"decreased":[181],"appetite":[182],"(31.0%/0.6%),":[183],"hyperglycemia":[184],"(30.4%/0%),":[185],"constipation":[186],"(27.2%/0.6%),":[187],"hyponatremia":[188],"(25.9%/1.3%).":[189],"1":[194,229,372],"patient":[195],"was":[196,203,212],"dead":[197],"due":[198],"febrile":[200],"that":[202],"assessed":[204],"be":[206],"related":[207],"No":[210],"ILD":[211],"observed.":[213],"147":[218],"efficacy":[221,296],"evaluable":[222],"(shown":[223],"table).":[226],"Note:":[227],"1.":[228],"pt":[230],"HER2+":[232],"1pt":[235],"who":[239,257],"didn\u2019t":[240],"receive":[241],"standard":[242],"treatment":[243],"because":[244],"poor":[246],"economic":[247],"condition":[248],"enrolled.":[250],"2.":[251],"NE,":[252],"Not":[253,289],"evaluable.":[254],"Including":[255],"no":[259],"post-baseline":[260],"scan":[261],"already":[263],"off":[264],"treatment.":[265],"3.":[266],"median":[268],"follow":[269],"up":[270],"time":[271],"PFS":[273],"8.5":[275],"months,":[276],"mOS":[279],"sub-group":[282],"are":[284,321],"not":[285],"reached.":[286,290],"4.":[287],"NR,":[288],"Conclusions:":[291],"has":[293],"demonstrated":[294],"encouraging":[295],"subtypes,":[308],"particularly":[309],"earlier":[311],"lines":[312],"therapy.":[314],"safety":[316],"tolerability":[318],"consistent":[322],"published":[325],"data.":[326],"Clinical":[327],"trial":[328],"information:":[329],"NCT05470348.":[330],"Citation":[331],"Format:":[332],"Jiong":[333],"Wu,":[334],"Jian":[335],"Zhang,":[336],"Yiqun":[337],"Du,":[338],"Yanchun":[339],"Meng,":[340],"Sa":[341],"Xiao,":[342],"Hai":[343],"Zhu,":[344],"Yi":[345],"Zhu.":[346],"BL-B01D1,":[347],"antibody-drug":[352],"conjugate,":[353],"Locally":[357],"Advanced":[358],"Metastatic":[360],"Breast":[361,381],"Cancer":[362,382,395],"Solid":[365],"Tumor:":[366],"Updated":[367],"results":[368],"[abstract].":[374],"In:":[375],"Proceedings":[376],"San":[379,388],"Antonio":[380],"Symposium":[383],"2024;":[384],"2024":[385],"Dec":[386],"10-13;":[387],"Antonio,":[389],"TX.":[390],"Philadelphia":[391],"(PA):":[392],"AACR;":[393],"Clin":[394],"Res":[396],"2025;31(12":[397],"Suppl):Abstract":[398],"nr":[399],"P5-07-27.":[400]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}